Tokyo Tape
Sign in
← Toho Holdings

Quarterly report · Q3

8129.TEDINET S100SULP
Period2023-04-01 → 2023-12-31
Filed2024-02-14
StandardJapan GAAP
ConsolidatedYes
Data checks12 of 12 passed
Key figures · 36
MetricValuePeriodScopeSource row
Revenue¥1.12T2023-04-01 → 2023-12-31Cons.Net sales
Revenue¥1.39T2022-04-01 → 2023-03-31Cons.Net sales (5-year summary)
Revenue¥1.06T2022-04-01 → 2022-12-31Cons.Net sales
Operating income¥11.6bn2023-04-01 → 2023-12-31Cons.Operating income
Operating income¥11.2bn2022-04-01 → 2022-12-31Cons.Operating income
Ordinary income¥13.6bn2023-04-01 → 2023-12-31Cons.Ordinary income
Ordinary income¥19.2bn2022-04-01 → 2023-03-31Cons.Ordinary income loss (5-year summary)
Ordinary income¥13.4bn2022-04-01 → 2022-12-31Cons.Ordinary income
Profit before tax¥20.3bn2023-04-01 → 2023-12-31Cons.Income before income taxes
Profit before tax¥14.4bn2022-04-01 → 2022-12-31Cons.Income before income taxes
Net income (owners)¥13.5bn2023-04-01 → 2023-12-31Cons.Profit loss attributable to owners of parent
Net income (owners)¥13.6bn2022-04-01 → 2023-03-31Cons.Profit loss attributable to owners of parent (5-year summary)
Net income (owners)¥9.5bn2022-04-01 → 2022-12-31Cons.Profit loss attributable to owners of parent
Net income¥13.5bn2023-04-01 → 2023-12-31Cons.Profit loss
Net income¥9.6bn2022-04-01 → 2022-12-31Cons.Profit loss
Total assets¥804.9bnat 2023-12-31Cons.Assets
Total assets¥715.3bnat 2023-03-31Cons.Assets
Total assets¥794.4bnat 2022-12-31Cons.Total assets (5-year summary)
Total liabilities¥561.2bnat 2023-12-31Cons.Liabilities
Total liabilities¥472.4bnat 2023-03-31Cons.Liabilities
Net assets / equity¥243.7bnat 2023-12-31Cons.Net assets
Net assets / equity¥242.9bnat 2023-03-31Cons.Net assets
Net assets / equity¥240.4bnat 2022-12-31Cons.Net assets (5-year summary)
Cash and deposits¥128.9bnat 2023-12-31Cons.Cash and deposits
Cash and deposits¥86.2bnat 2023-03-31Cons.Cash and deposits
EPS (basic)¥207.252023-04-01 → 2023-12-31Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥73.142023-10-01 → 2023-12-31dCons.Basic earnings loss per share (5-year summary)
EPS (basic)¥196.72022-04-01 → 2023-03-31Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥136.092022-04-01 → 2022-12-31Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥85.92022-10-01 → 2022-12-31dCons.Basic earnings loss per share (5-year summary)
EPS (diluted)¥186.22023-04-01 → 2023-12-31Cons.Diluted earnings per share (5-year summary)
EPS (diluted)¥180.672022-04-01 → 2023-03-31Cons.Diluted earnings per share (5-year summary)
EPS (diluted)¥125.12022-04-01 → 2022-12-31Cons.Diluted earnings per share (5-year summary)
Equity ratio30.3%at 2023-12-31Cons.Equity to asset ratio (5-year summary)
Equity ratio33.9%at 2023-03-31Cons.Equity to asset ratio (5-year summary)
Equity ratio30.2%at 2022-12-31Cons.Equity to asset ratio (5-year summary)

Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.

Segments · 46
SegmentItemPeriodValue
Reconciling Itemsreconcilingrevenue2023-04-01 → 2023-12-31−¥44.5bn
Reconciling Itemsreconcilingrevenue intersegment2023-04-01 → 2023-12-31−¥44.5bn
Reconciling Itemsreconcilingsegment profit2023-04-01 → 2023-12-31−¥2.6bn
jpcrp040300-q3r_E02608-000Dispensing Pharmacyreportable segmentrevenue2023-04-01 → 2023-12-31¥70.4bn
jpcrp040300-q3r_E02608-000Dispensing Pharmacyreportable segmentrevenue external2023-04-01 → 2023-12-31¥70.4bn
jpcrp040300-q3r_E02608-000Dispensing Pharmacyreportable segmentrevenue intersegment2023-04-01 → 2023-12-31¥9m
jpcrp040300-q3r_E02608-000Dispensing Pharmacyreportable segmentsegment profit2023-04-01 → 2023-12-31¥1.4bn
jpcrp040300-q3r_E02608-000Medical Products Manufacturing And Salesreportable segmentrevenue2023-04-01 → 2023-12-31¥8.0bn
jpcrp040300-q3r_E02608-000Medical Products Manufacturing And Salesreportable segmentrevenue external2023-04-01 → 2023-12-31¥1.8bn
jpcrp040300-q3r_E02608-000Medical Products Manufacturing And Salesreportable segmentrevenue intersegment2023-04-01 → 2023-12-31¥6.2bn
jpcrp040300-q3r_E02608-000Medical Products Manufacturing And Salesreportable segmentsegment profit2023-04-01 → 2023-12-31¥686m
jpcrp040300-q3r_E02608-000Medical Products Retailreportable segmentrevenue2023-04-01 → 2023-12-31¥1.08T
jpcrp040300-q3r_E02608-000Medical Products Retailreportable segmentrevenue external2023-04-01 → 2023-12-31¥1.04T
jpcrp040300-q3r_E02608-000Medical Products Retailreportable segmentrevenue intersegment2023-04-01 → 2023-12-31¥37.3bn
jpcrp040300-q3r_E02608-000Medical Products Retailreportable segmentsegment profit2023-04-01 → 2023-12-31¥11.8bn
jpcrp040300-q3r_E02608-000Other Related Businessreportable segmentrevenue2023-04-01 → 2023-12-31¥4.4bn
jpcrp040300-q3r_E02608-000Other Related Businessreportable segmentrevenue external2023-04-01 → 2023-12-31¥3.4bn
jpcrp040300-q3r_E02608-000Other Related Businessreportable segmentrevenue intersegment2023-04-01 → 2023-12-31¥1.0bn
jpcrp040300-q3r_E02608-000Other Related Businessreportable segmentsegment profit2023-04-01 → 2023-12-31¥258m
Total Of Reportable Segments And Otherssegment totalrevenue2023-04-01 → 2023-12-31¥1.16T
Total Of Reportable Segments And Otherssegment totalrevenue external2023-04-01 → 2023-12-31¥1.12T
Total Of Reportable Segments And Otherssegment totalrevenue intersegment2023-04-01 → 2023-12-31¥44.5bn
Total Of Reportable Segments And Otherssegment totalsegment profit2023-04-01 → 2023-12-31¥14.2bn
Reconciling Itemsreconcilingrevenue2022-04-01 → 2022-12-31−¥43.4bn
Reconciling Itemsreconcilingrevenue intersegment2022-04-01 → 2022-12-31−¥43.4bn
Reconciling Itemsreconcilingsegment profit2022-04-01 → 2022-12-31−¥1.1bn
jpcrp040300-q3r_E02608-000Dispensing Pharmacyreportable segmentrevenue2022-04-01 → 2022-12-31¥68.8bn
jpcrp040300-q3r_E02608-000Dispensing Pharmacyreportable segmentrevenue external2022-04-01 → 2022-12-31¥68.8bn
jpcrp040300-q3r_E02608-000Dispensing Pharmacyreportable segmentrevenue intersegment2022-04-01 → 2022-12-31¥4m
jpcrp040300-q3r_E02608-000Dispensing Pharmacyreportable segmentsegment profit2022-04-01 → 2022-12-31¥1.7bn
jpcrp040300-q3r_E02608-000Medical Products Manufacturing And Salesreportable segmentrevenue2022-04-01 → 2022-12-31¥7.4bn
jpcrp040300-q3r_E02608-000Medical Products Manufacturing And Salesreportable segmentrevenue external2022-04-01 → 2022-12-31¥1.6bn
jpcrp040300-q3r_E02608-000Medical Products Manufacturing And Salesreportable segmentrevenue intersegment2022-04-01 → 2022-12-31¥5.8bn
jpcrp040300-q3r_E02608-000Medical Products Manufacturing And Salesreportable segmentsegment profit2022-04-01 → 2022-12-31¥715m
jpcrp040300-q3r_E02608-000Medical Products Retailreportable segmentrevenue2022-04-01 → 2022-12-31¥1.02T
jpcrp040300-q3r_E02608-000Medical Products Retailreportable segmentrevenue external2022-04-01 → 2022-12-31¥986.2bn
jpcrp040300-q3r_E02608-000Medical Products Retailreportable segmentrevenue intersegment2022-04-01 → 2022-12-31¥36.4bn
jpcrp040300-q3r_E02608-000Medical Products Retailreportable segmentsegment profit2022-04-01 → 2022-12-31¥9.4bn
jpcrp040300-q3r_E02608-000Other Related Businessreportable segmentrevenue2022-04-01 → 2022-12-31¥4.9bn
jpcrp040300-q3r_E02608-000Other Related Businessreportable segmentrevenue external2022-04-01 → 2022-12-31¥3.8bn
jpcrp040300-q3r_E02608-000Other Related Businessreportable segmentrevenue intersegment2022-04-01 → 2022-12-31¥1.2bn
jpcrp040300-q3r_E02608-000Other Related Businessreportable segmentsegment profit2022-04-01 → 2022-12-31¥449m
Total Of Reportable Segments And Otherssegment totalrevenue2022-04-01 → 2022-12-31¥1.10T
Total Of Reportable Segments And Otherssegment totalrevenue external2022-04-01 → 2022-12-31¥1.06T
Total Of Reportable Segments And Otherssegment totalrevenue intersegment2022-04-01 → 2022-12-31¥43.4bn
Total Of Reportable Segments And Otherssegment totalsegment profit2022-04-01 → 2022-12-31¥12.3bn

Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.

All source rows · 419
ItemContextValueUnit
Other noiPrior1YTDDuration766000000JPY
Other noiCurrentYTDDuration518000000JPY
Non operating incomePrior1YTDDuration2615000000JPY
Non operating incomeCurrentYTDDuration2452000000JPY
Interest expenses noePrior1YTDDuration54000000JPY
Interest expenses noeCurrentYTDDuration46000000JPY
Rent expenses on real estates noePrior1YTDDuration160000000JPY
Rent expenses on real estates noeCurrentYTDDuration135000000JPY
Other noePrior1YTDDuration144000000JPY
Other noeCurrentYTDDuration234000000JPY
Non operating expensesPrior1YTDDuration358000000JPY
Non operating expensesCurrentYTDDuration415000000JPY
Ordinary incomePrior1YTDDuration13428000000JPY
Ordinary incomeCurrentYTDDuration13618000000JPY
Gain on sales of noncurrent assets eiPrior1YTDDuration115000000JPY
Gain on sales of noncurrent assets eiCurrentYTDDuration22000000JPY
Gain on sales of investment securities eiPrior1YTDDuration2784000000JPY
Gain on sales of investment securities eiCurrentYTDDuration6686000000JPY
Other eiPrior1YTDDuration19000000JPY
Other eiCurrentYTDDuration215000000JPY
Extraordinary incomePrior1YTDDuration2920000000JPY
Extraordinary incomeCurrentYTDDuration6924000000JPY
Loss on disposal of noncurrent assets elPrior1YTDDuration113000000JPY
Loss on disposal of noncurrent assets elCurrentYTDDuration139000000JPY
Impairment loss elPrior1YTDDuration26000000JPY
Impairment loss elCurrentYTDDuration－JPY
Loss on valuation of stocks of subsidiaries and affiliates elPrior1YTDDuration－JPY
Loss on valuation of stocks of subsidiaries and affiliates elCurrentYTDDuration122000000JPY
Provision for loss on anti monopoly act elPrior1YTDDuration1400000000JPY
Provision for loss on anti monopoly act elCurrentYTDDuration－JPY
Other elPrior1YTDDuration359000000JPY
Other elCurrentYTDDuration8000000JPY
Extraordinary lossPrior1YTDDuration1900000000JPY
Extraordinary lossCurrentYTDDuration269000000JPY
Income before income taxesPrior1YTDDuration14448000000JPY
Income before income taxesCurrentYTDDuration20273000000JPY
Income taxes currentPrior1YTDDuration4737000000JPY
Income taxes currentCurrentYTDDuration6632000000JPY
Income taxes deferredPrior1YTDDuration159000000JPY
Income taxes deferredCurrentYTDDuration160000000JPY
Income taxesPrior1YTDDuration4897000000JPY
Income taxesCurrentYTDDuration6792000000JPY
Profit lossPrior1YTDDuration9551000000JPY
Profit lossCurrentYTDDuration13480000000JPY
Profit loss attributable to non controlling interestsPrior1YTDDuration17000000JPY
Profit loss attributable to non controlling interestsCurrentYTDDuration10000000JPY
Profit loss attributable to owners of parentPrior1YTDDuration9534000000JPY
Profit loss attributable to owners of parentCurrentYTDDuration13470000000JPY
Profit lossPrior1YTDDuration9551000000JPY
Profit lossCurrentYTDDuration13480000000JPY

Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.

Data checks · 12 of 12 passed
balance sheet identityconsolidated 2023-03-31pass
balance sheet identityconsolidated 2023-12-31pass rounding
dei present pass
period resolution pass
statement vs summary · net assetsconsolidated 2023-03-31pass
statement vs summary · net assetsconsolidated 2023-12-31pass
statement vs summary · net income attributable to parentconsolidated 2022-04-01/2022-12-31pass
statement vs summary · net income attributable to parentconsolidated 2023-04-01/2023-12-31pass
statement vs summary · revenueconsolidated 2022-04-01/2022-12-31pass
statement vs summary · revenueconsolidated 2023-04-01/2023-12-31pass
statement vs summary · total assetsconsolidated 2023-03-31pass
statement vs summary · total assetsconsolidated 2023-12-31pass